XRTX (XORTX Therapeutics Inc. Common Stock) Stock Analysis - Politician Trades

XORTX Therapeutics Inc. Common Stock (XRTX) is a publicly traded Healthcare sector company. As of May 19, 2026, XRTX trades at $2.53 with a market cap of $4.01M and a P/E ratio of 0.00. XRTX moved +0.00% today. Year to date, XRTX is -8.77%; over the trailing twelve months it is -51.40%. Its 52-week range spans $1.73 to $12.55. Rallies surfaces XRTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded XRTX stock?

Rallies tracks politician and congressional stock disclosures for XRTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

XRTX Key Metrics

Key financial metrics for XRTX
MetricValue
Price$2.53
Market Cap$4.01M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$12.55
52-Week Low$1.73
Volume3.33K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XRTX News

XRTX Analyst Consensus

XRTX analyst coverage data. Average price target: $0.00.

Common questions about XRTX

Which politicians traded XRTX stock?
Rallies tracks politician and congressional stock disclosures for XRTX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in XRTX?
Yes. Rallies tracks politician and congressional stock disclosures for XRTX, including reported purchases, sales, dates, owners, and trade amounts when available.
Is XRTX research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XRTX. It does not provide personalized investment advice.
XRTX

XRTX